.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
Johnson and Johnson
Citi
Covington
AstraZeneca
McKinsey
Daiichi Sankyo
Mallinckrodt
Harvard Business School

Generated: November 22, 2017

DrugPatentWatch Database Preview

Aqua Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for AQUA PHARMS LLC, and when can generic versions of AQUA PHARMS LLC drugs launch?

AQUA PHARMS LLC has three approved drugs.

There are three US patents protecting AQUA PHARMS LLC drugs.

There are sixty-three patent family members on AQUA PHARMS LLC drugs in thirty-five countries and thirteen supplementary protection certificates in nine countries.

Summary for Aqua Pharms Llc

International Patents:63
US Patents:3
Tradenames:3
Ingredients:3
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aqua Pharms Llc
ALTABAX
retapamulin
OINTMENT;TOPICAL022055-001Apr 12, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
Aqua Pharms Llc
ACTICLATE
doxycycline hyclate
TABLET;ORAL205931-001Jul 25, 2014ABRXYesNo► Subscribe► Subscribe► Subscribe
Aqua Pharms Llc
ACTICLATE
doxycycline hyclate
TABLET;ORAL205931-002Jul 25, 2014ABRXYesYes► Subscribe► Subscribe► Subscribe
Aqua Pharms Llc
ALTABAX
retapamulin
OINTMENT;TOPICAL022055-001Apr 12, 2007RXYesYes► Subscribe► SubscribeYY ► Subscribe
Aqua Pharms Llc
VELTIN
clindamycin phosphate; tretinoin
GEL;TOPICAL050803-001Jul 16, 2010BXRXYesYes► Subscribe► Subscribe► Subscribe
Aqua Pharms Llc
ALTABAX
retapamulin
OINTMENT;TOPICAL022055-001Apr 12, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Aqua Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aqua Pharms Llc
VELTIN
clindamycin phosphate; tretinoin
GEL;TOPICAL050803-001Jul 16, 2010► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Aqua Pharms Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,281,226 Pleuromutilin derivatives as antimicrobials► Subscribe
RE39128Pleuromutilin derivatives as antimicrobials► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Aqua Pharms Llc Drugs

Country Document Number Estimated Expiration
Japan2012020998► Subscribe
China1205211► Subscribe
Norway327392► Subscribe
Denmark1028961► Subscribe
Japan2007504231► Subscribe
Czech Republic298543► Subscribe
China1283197► Subscribe
Slovenia1930330► Subscribe
Japan2009040789► Subscribe
European Patent Office2181995► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Aqua Pharms Llc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB07/061United Kingdom► SubscribePRODUCT NAME: RETAPAMULIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/07/390/001 20070524; UK EU/1/07/390/002 20070524; UK EU/1/07/390/003 20070524; UK EU/1/07/390/004 20070524
C0057France► SubscribePRODUCT NAME: RETAPAMULIN; REGISTRATION NO/DATE IN FRANCE: EU/1/07/390/001 DU 20070524; REGISTRATION NO/DATE AT EEC: EU/1/07/390/001 DU 20070524
2007 00052Denmark► Subscribe
C042/2007Ireland► SubscribeSPC042/2007: 20080415, EXPIRES: 20220523
401Luxembourg► SubscribePRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
1304992/01Switzerland► SubscribePRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
2013025,C1304992Lithuania► SubscribePRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
00617Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
372Luxembourg► Subscribe91372, EXPIRES: 20220524
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Cantor Fitzgerald
Cipla
Merck
Julphar
Daiichi Sankyo
Fish and Richardson
Baxter
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot